Fortis Healthcare files Supreme Court petition against Delhi HC order
- Fortis Healthcare filed an SLP in the Supreme Court on September 16, 2026
- The petition challenges a Delhi High Court judgment dated August 31, 2026
- The case involves litigation with Daiichi Sankyo Company Limited
- The company stated there are no expected financial implications
*this image is generated using AI for illustrative purposes only.
Fortis Healthcare filed a Special Leave Petition (SLP) before the Supreme Court of India on September 16, 2026. The move challenges an August 31, 2026 judgment by the Delhi High Court in ongoing litigation with Daiichi Sankyo Company Limited.
The filing, submitted at 2:54 am, pertains to specific applications within the case titled Daiichi Sankyo Company, Limited vs. Malvinder Mohan Singh And Ors. (O.M.P.(EFA)(COMM.) 6/2016). The applications involved are EX.APPL.(OS) 3764/2022, EX.APPL.(OS) 1615/2025, and EX.APPL.(OS) 3763/2022.
Regulatory Disclosure
The company made the disclosure pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This action follows earlier disclosures dated September 1, 2026, regarding the same legal matter.
Litigation Details
| Particulars | Details |
|---|---|
| Opposing Party | Daiichi Sankyo Company Limited |
| Court | Supreme Court of India (SLP filed against Delhi HC order) |
| Case Title | Daiichi Sankyo Company, Limited vs. Malvinder Mohan Singh And Ors. |
| Financial Implications | N/A |
| Quantum of Claims | N/A |
Fortis Healthcare stated that there are no expected financial implications or quantifiable claims associated with this specific filing. The company noted that details regarding the underlying order were previously disclosed to the exchanges.
Satyendra Chauhan, Company Secretary and Compliance Officer, signed the disclosure on behalf of the company.
Historical Stock Returns for Fortis Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.43% | -4.46% | -6.62% | +3.30% | -11.27% | +216.26% |
How might the Supreme Court's eventual ruling on this SLP impact Fortis Healthcare's broader corporate governance structure and leadership stability?
Could the prolonged litigation with Daiichi Sankyo affect investor sentiment or credit ratings for Fortis Healthcare despite the stated lack of immediate financial implications?
What strategic advantages might Fortis gain if the Supreme Court overturns the Delhi High Court's judgment regarding the specific applications cited?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
